|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
2/16/2012 7:22:44 AM
Sanofi, France’s biggest drugmaker, recalled 9,380 vials of the leukemia medicine Fludara because of a “lack of assurance of sterility,” U.S. regulators said. Genzyme, a unit of Paris-based Sanofi, notified customers of the recall of the intravenous drug on Jan. 31 and Feb. 1, the Food and Drug Administration said today in an enforcement report on its website. The nationwide recall was prompted by manufacturing deficiencies at Boehringer Ingelheim GmbH’s Ben Venue Laboratories that produced Fludara. Boehringer, the world’s largest family-owned drugmaker, closed the factory in Bedford, Ohio, last year after U.S. and European regulators discovered the violations.
|
|
|
|
|
|
|
|
|
|
|